We also find that RelB drives resistance of OxPhos-DLBCL cells to apoptosis induced by mitochondrial metabolic stress upon treatment with either Metformin or L-asparaginase (®Kidrolase), two approved anti-metabolic drugs, or glutamine deprivation. Here, RELB is linked to diffuse large B-cell lymphoma.